LONDON (AP) - Researchers say it's possible aspirin could be helpful for people with a genetic susceptibility to colon cancer.
The study suggests a daily dose of aspirin could cut their chances of developing the disease in half.
The finding might lead to other treatments by helping researchers understand how aspirin combats colon cancer, one of the top three cancers in rich countries.
European researchers followed more than 1,000 people with a genetic mutation that makes them vulnerable to various cancers.
About half got aspirin daily while the other half got placebo pills for about four years.
Six people in the aspirin group developed colon cancer, versus 16 in the group that got placebos.
Study leader John Burn of Newcastle University in Britain presented the results today in Berlin at a meeting of the European Cancer Organisation.